Page 14 - Demo

Z
Z
h
h
i
i
q
qu
u
n
nL
L
i
in
n
■N
nal University of Singapore
■
n
N
a
a
t
t
i
i
o
o
C
Contribution to the Science/Profession: Recognized for pioneering general and robust polymer
J
s
e
L
i
i
i
n
n
g
g
b
o
L
o
b
o
L
o
u
u
i
i
s
e
L
i
u
c
c
h
hemistry for precision synthesis of nanocrystals with controlled dimensions, compositions,
rchitectures, and surface chemistry for energy conversion and storage.
C
mers and materials chemistry communities through engagement with its technical divisions, m
a
a
r
Contribution to the ACS Community: Recognized for outstanding service to the ACS poly-
s
s
ubstantial membership and reviewing activities, and mentoring of colleagues and students.
u
J
u ■ Texas A&M University-Kingsville
Contribution to the Science/Profession: Invented amphiphilic functionalization of platinum nanotubes-based proton-exchange membrane fuel cells (FC). ThThe discovery increased catalytic FC performance with a concomitant reduction of 87,000 tons of potential CO2 per year.
Contribution to the ACS Community: Serves on the Executive Committee of the Division of Energy and Fuels. Led new initiatives, coordinated activities during COVID-19, and increased access and opportunities for graduate students on chemical science and practice.
Muthiah (Mano) Manoharan ■ Alnylam Pharmaceuticals
Contribution to the Science/Profession: Recognized for pioneering chemistry in nucleic acid therapeutics, lipid-nanoparticle (LNP) and GalNAc-conjugate mediated delivery platforms, which enabled fifive approved RNAi therapeutics, >25 siRNAs, and >25 antisense oligonucle- otides in clinical trials.
Contribution to the ACS Community: Recognized for leadership of the Carbohydrate Division of the ACS. Numerous symposia organizer/speaker for the Carbohydrate, Medicinal Chemis- try, Organic Chemistry, and Chemical Biology Divisions focused on medicinal chemistry and delivery of oligonucleotide therapeutics.
Brian M. Mathes ■ Elanco Animal Health
Contribution to the Science/Profession: Recognized for outstanding contributions to drug discovery synthesis and modeling that led to substantial progress in the development of new pharmaceutical options in Alzheimer’s, diabetes, and migraine headache treatments.
Contribution to the ACS Community: Recognized for exceptional local, regional, and national ACS service as Committee Membership Affairs (MAC) Chair, leading MAC and ACS mem- bership category change initiatives to enhance the size and scope of ACS membership.
7 l 2022 CLASS OF ACS FELLOWS